Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis
Clinical trial NCT06224608 · COMPLETED
Trial details
- NCT number
- NCT06224608
- Sponsor
- Chengdu CoenBiotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-17
- Primary completion
- 2023-05-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.